Shanghai Fosun Pharmaceutical Group Co Ltd (600196) — Cash Flow Quality Index
Shanghai Fosun Pharmaceutical Group Co Ltd (600196) has a Cash Flow Quality Index of 2.83x as of December 2025. Operating cash flow of CN¥2.40 Billion exceeds net income of CN¥847.27 Million, indicating high earnings quality where cash backs reported profits. Explore 600196 operating cash flow to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Shanghai Fosun Pharmaceutical Group Co Ltd Cash Flow Quality Index (1998–2025)
Historical Cash Flow Quality Index for Shanghai Fosun Pharmaceutical Group Co Ltd across 28 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 600196 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Shanghai Fosun Pharmaceutical Group Co Ltd (1998–2025)
Year-by-year earnings quality comparison for Shanghai Fosun Pharmaceutical Group Co Ltd. For live market cap and the full company financial profile, see market value of Shanghai Fosun Pharmaceutical Group Co L.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.78x | CN¥6.01 Billion | CN¥3.37 Billion | ▲ +39.8% |
| 2024 | 1.27x | CN¥4.48 Billion | CN¥3.51 Billion | ▼ -30.3% |
| 2023 | 1.83x | CN¥4.36 Billion | CN¥2.39 Billion | ▲ +71.1% |
| 2022 | 1.07x | CN¥4.22 Billion | CN¥3.95 Billion | ▲ +34.9% |
| 2021 | 0.79x | CN¥3.95 Billion | CN¥4.99 Billion | ▲ +20.9% |
| 2020 | 0.65x | CN¥2.58 Billion | CN¥3.94 Billion | ▼ -23.9% |
| 2019 | 0.86x | CN¥3.22 Billion | CN¥3.74 Billion | ▼ -11.9% |
| 2018 | 0.98x | CN¥2.95 Billion | CN¥3.02 Billion | ▲ +35.7% |
| 2017 | 0.72x | CN¥2.58 Billion | CN¥3.59 Billion | ▲ +9.9% |
| 2016 | 0.66x | CN¥2.11 Billion | CN¥3.22 Billion | ▲ +16.0% |
| 2015 | 0.56x | CN¥1.62 Billion | CN¥2.87 Billion | ▲ +11.5% |
| 2014 | 0.51x | CN¥1.20 Billion | CN¥2.37 Billion | ▲ +20.1% |
| 2013 | 0.42x | CN¥1.01 Billion | CN¥2.40 Billion | ▲ +16.5% |
| 2012 | 0.36x | CN¥665.52 Million | CN¥1.84 Billion | ▲ +58.2% |
| 2011 | 0.23x | CN¥316.65 Million | CN¥1.38 Billion | ▲ +12.5% |
| 2010 | 0.20x | CN¥203.36 Million | CN¥1.00 Billion | ▲ +99.1% |
| 2009 | 0.10x | CN¥261.87 Million | CN¥2.56 Billion | ▼ -66.7% |
| 2008 | 0.31x | CN¥233.04 Million | CN¥760.93 Million | ▲ +60.8% |
| 2007 | 0.19x | CN¥131.48 Million | CN¥690.19 Million | ▼ -69.8% |
| 2006 | 0.63x | CN¥184.91 Million | CN¥292.83 Million | ▼ -20.2% |
| 2005 | 0.79x | CN¥188.35 Million | CN¥237.94 Million | ▲ +8.9% |
| 2004 | 0.73x | CN¥205.10 Million | CN¥282.09 Million | ▲ +44.4% |
| 2003 | 0.50x | CN¥150.14 Million | CN¥298.18 Million | ▼ -20.5% |
| 2002 | 0.63x | CN¥102.47 Million | CN¥161.75 Million | ▲ +31.2% |
| 2001 | 0.48x | CN¥68.15 Million | CN¥141.08 Million | ▼ -52.6% |
| 2000 | 1.02x | CN¥138.43 Million | CN¥135.79 Million | ▲ +152.0% |
| 1999 | 0.40x | CN¥38.20 Million | CN¥94.43 Million | ▼ -60.5% |
| 1998 | 1.03x | CN¥66.55 Million | CN¥64.93 Million | — |